Clinical Study With Lyrica In Patients Suffering From Epilepsy
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Clinical study with Lyrica (pregabalin) in patients suffering from epilepsy. This drug is
used as adjunctive therapy with one or more antiepileptics. Lyrica has potential to reduce
seizure frequency.
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.